Orencia 250 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XUT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,623
Award facts
- Contract value 100% obligated
- $7,623.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,623.40 on September 26, 2025, for the supply of Orencia 250 mg vials. This firm fixed-price delivery order, issued without a set-aside designation, is performed at the contractor's Park Ridge location and has an ultimate completion date of September 29, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain and represents a continuation of the agency's pharmaceutical procurement activities supporting military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price orders for comprehensive pharmaceutical products. The contractor has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing delivery orders for branded and generic prescription drugs, biologics, and specialized medical products to support Department of Defense healthcare operations. Orencia (abatacept), a biologic immunosuppressant medication, represents the type of specialized pharmaceutical product that DMS Pharmaceutical Group regularly distributes to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6XUT?
SPE2DX25F6XUT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 26, 2025.
How much is contract SPE2DX25F6XUT worth?
The government has obligated $7,623 on SPE2DX25F6XUT.
Is contract SPE2DX25F6XUT an order under another contract?
Yes. SPE2DX25F6XUT is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUT competed?
The extent of competition for SPE2DX25F6XUT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award